• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>GlaxoSmithKline

GlaxoSmithKline

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. GlaxoSmithKline Starts Phase III Studies with Daprodustat

    GlaxoSmithKline Starts Phase III Studies with Daprodustat

  2. GSK Files Regulatory Submission in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

    GSK Files Regulatory Submission in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

  3. Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD

    Relvar® Ellipta® 100/25 mcg Gains Approval in Japan for Use in Patients with COPD

  4. FTSE 100 pulls back as pound strengthens, but oil shares hold gains

    FTSE 100 pulls back as pound strengthens, but oil shares hold gains

  5. LONDON MARKETS: FTSE 100 Pulls Back As Pound Strengthens, But Oil Shares Hold Gains

    LONDON MARKETS: FTSE 100 Pulls Back As Pound Strengthens, But Oil Shares Hold Gains

  6. Global Alopecia Drugs Market - Analysis, Technolgies & Forecasts to 2020 - Key Vendors are GlaxoSmithKline , Johnson & Johnson & Merck - Research and Markets

    Global Alopecia Drugs Market - Analysis, Technolgies & Forecasts to 2020 - Key Vendors are GlaxoSmithKline , Johnson & Johnson & Merck - Research and Markets

  7. Seattle Genetics Presents Data from Phase 2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Diffuse Large B-cell Lymphoma at ASH Annual Meeting

    Seattle Genetics Presents Data from Phase 2 Study Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Diffuse Large B-cell Lymphoma at ASH Annual Meeting

  8. Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A; 33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual Meeting

    Seattle Genetics Presents Phase 1b Data from Vadastuximab Talirine (SGN-CD33A; 33A) in Combination with Standard of Care in Frontline Acute Myeloid Leukemia at ASH Annual Meeting

  9. Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

    Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

  10. Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Research and Markets

    Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.